protoporphyrin ix has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 6 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, X | 2 |
| Wang, X | 2 |
| Liu, Q | 2 |
| Wang, P | 2 |
| Xu, C | 1 |
| Leung, AW | 1 |
| Jia, Y | 1 |
| Zhang, K | 1 |
| Feng, X | 1 |
| Sol, V | 1 |
| Lamarche, F | 1 |
| Enache, M | 1 |
| Garcia, G | 1 |
| Granet, R | 1 |
| Guilloton, M | 1 |
| Blais, JC | 1 |
| Krausz, P | 1 |
| Macho, A | 1 |
| Calzado, MA | 1 |
| Jiménez-Reina, L | 1 |
| Ceballos, E | 1 |
| León, J | 1 |
| Muñoz, E | 1 |
| Koiso, Y | 1 |
| Nakajima, O | 1 |
| Matsumura, D | 1 |
| Fujimoto, Y | 1 |
| Hashimoto, Y | 1 |
| Eléouet, S | 1 |
| Rousset, N | 1 |
| Carré, J | 1 |
| Vonarx, V | 1 |
| Vilatte, C | 1 |
| Louët, C | 1 |
| Lajat, Y | 1 |
| Patrice, T | 1 |
1 review available for protoporphyrin ix and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
[Chemical control of cell differentiation of human myeloleukemia K562 cell line].
Topics: Cell Differentiation; Erythroblasts; Heme Oxygenase (Decyclizing); Hemin; Humans; K562 Cells; Leukem | 2000 |
1 trial available for protoporphyrin ix and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Heterogeneity of delta-aminolevulinic acid-induced protoporphyrin IX fluorescence in human glioma cells and leukemic lymphocytes.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy; Brain Neoplasms; Female; Glioblastoma; | 2000 |
4 other studies available for protoporphyrin ix and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
The role of Beclin 1 in SDT-induced apoptosis and autophagy in human leukemia cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspase 3; Fluorescent Dyes; Gene Kno | 2015 |
Combination of Protoporphyrin IX-mediated Sonodynamic Treatment with Doxorubicin Synergistically Induced Apoptotic Cell Death of a Multidrug-Resistant Leukemia K562/DOX Cell Line.
Topics: Antibiotics, Antineoplastic; Apoptosis; Combined Modality Therapy; Doxorubicin; Drug Resistance, Mul | 2015 |
Polyamine conjugates of meso-tritolylporphyrin and protoporphyrin IX: potential agents for photodynamic therapy of cancers.
Topics: Antineoplastic Agents; Dihematoporphyrin Ether; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Posi | 2006 |
Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms.
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspase Inhibitors; Caspases; Cell | 1999 |